Delayed recovery of serum immunoglobulin G is a poor prognostic marker in patients with follicular lymphoma treated with rituximab maintenance-Reference-Cited by-同舟云学术

Delayed recovery of serum immunoglobulin G is a poor prognostic marker in patients with follicular lymphoma treated with rituximab maintenance

Published:2017-11-14 Issue:2 Volume:97 Page:289-297
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Kusano Yoshiharu^ORCID,Yokoyama Masahiro,Inoue Norihito,Yamauchi Hirofumi,Takahashi Anna,Tsuyama Naoko,Mishima Yuko,Nishimura Noriko,Takeuchi Kengo,Terui Yasuhito,Hatake Kiyohiko

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s00277-017-3175-7/fulltext.html

Reference46 articles.

1. Reff ME, Carner K, Chambers KS, Chinn PC, Leonard JE, Raab R, Newman RA, Hanna N, Anderson DR (1994) Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 83(2):435–445

2. Maloney DG, Smith B, Rose A (2002) Rituximab: mechanism of action and resistance. Semin Oncol 2–9(suppl 2):29

3. Shan D, Ledbetter JA, Press OW (1998) Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies. Blood 91(5):1644–1652

4. Hochster H, Weller E, Gascoyne RD, Habermann TM, Gordon LI, Ryan T, Zhang L, Colocci N, Frankel S, Horning SJ (2009) Maintenance rituximab after cyclophosphamide, vincristine, and prednisone prolongs progression-free survival in advanced indolent lymphoma: results of the randomized phase III ECOG1496 study. J Clin Oncol 27(10):1607–1614. https://doi.org/10.1200/JCO.2008.17.1561

5. Hainsworth JD, Litchy S, Burris HA et al (2002) Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin’s lymphoma. J Clin Oncol 20(20):4261–4267. https://doi.org/10.1200/JCO.2002.08.674

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low number of intrafollicular T cells may predict favourable response to rituximab-based immuno-chemotherapy in advanced follicular lymphoma: a secondary analysis of a randomized clinical trial;Journal of Cancer Research and Clinical Oncology;2019-07-04

2. Secondary antibody deficiency in neurology;Current Opinion in Allergy & Clinical Immunology;2018-12

3. IgE deficiency and prior diagnosis of malignancy;Annals of Allergy, Asthma & Immunology;2018-11